Clinical trial No longer in our active list Phase 3 Interventional Ages 18 and up

Investigating retatrutide for Type 2 Diabetes with kidney issues

Official title: A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Placebo in Adult Participants With Type 2 Diabetes, Moderate or Severe Renal Impairment With Inadequate Glycemic Control on Basal Insulin With or Without Metformin and/or SGLT2 Inhibitor

Run by Eli Lilly and Company · NCT06297603 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study tests if a new medication called retatrutide can help people with Type 2 Diabetes and kidney problems better control their blood sugar compared to a placebo.

More Type 2 Diabetes trials Research outlook What's coming for Type 2 diabetes: the next 6 months to 5 years

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment320 (estimated)
SponsorEli Lilly and Company
Industry-sponsored
Locations80 sites (Huntsville, Alabama and 79 other locations)
Trial IDNCT06297603 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with Type 2 Diabetes, moderate to severe renal impairment, and inadequate glycemic control on their current diabetes regimen.

Probably not a fit

Patients with Type 1 Diabetes or those with a history of severe hypoglycemia or unstable renal disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the efficacy and safety of retatrutide compared to a placebo in individuals with Type 2 Diabetes who also have moderate or severe renal impairment and are not achieving adequate glycemic control on basal insulin, with or without additional medications like metformin or SGLT2 inhibitors. The trial will last approximately 14 months and may involve up to 22 visits for participants. It focuses on patients who have been on stable diabetes treatment prior to screening and have specific HbA1c levels.

Why it matters

Potential benefit: If successful, this treatment could significantly improve glycemic control in patients with Type 2 Diabetes and renal impairment.

How similar studies have gone: Other studies have shown promise in treating Type 2 Diabetes with similar approaches, but this specific combination is being explored for the first time.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have Type 2 Diabetes (T2D)
* Have HbA1c ≥7.0% (53 millimoles per mole (mmol/mol)) to ≤10.5% (91 mmol/mol)
* Have moderate or severe renal impairment
* Have been on the following stable diabetes treatment during 90 days prior to screening

  * basal insulin (≥20 International Units (IU)/day) with or without
  * metformin and/or SGLT2 inhibitor
* Are of stable weight for at least 90 days prior to screening
* Have a Body Mass Index (BMI) ≥23.0 kilograms per meter squared (kg/m2)

Exclusion Criteria:

* Have Type 1 Diabetes (T1D)
* Have a history of ketoacidosis or hyperosmolar state or coma within the last 6 months prior to screening
* Have a history of severe hypoglycemia or hypoglycemia unawareness within the last 6 months prior to screening
* Are currently receiving or planning to receive treatment for diabetic retinopathy and/or macular edema
* Have a history of unstable or rapidly progressing renal disease
* Have a prior or planned surgical treatment for obesity
* Have New York Heart Association Functional Classification III or IV congestive heart failure
* Have had acute myocardial infarction, stroke, or were hospitalized for congestive heart failure within 90 days prior to screening
* Have a known clinically significant gastric emptying abnormality
* Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy for less than 5 years
* Have a family or personal history of medullary thyroid carcinoma or multiple endocrine neoplasia (MEN) syndrome Type 2.
* Have any lifetime history of a suicide attempt
* Had chronic or acute pancreatitis
* Have taken prescribed or over-the-counter medication, or alternative remedies, intended to promote body weight reduction within 90 days prior to screening

Where it's running

  • Nephrology Consultants
    Huntsville, Alabama, United States
    Recruiting
  • Clinical Research Institute of Arizona (CRI) - Sun City West
    Sun City West, Arizona, United States
    Recruiting
  • Kidney & Hypertension Center - Apple Valley
    Apple Valley, California, United States
    Recruiting
  • Hope Clinical Research, Inc.
    Canoga Park, California, United States
    Recruiting
  • Neighborhood Healthcare Institute of Health
    Escondido, California, United States
    Recruiting
  • EndoTrials Center for Clinical Research
    La Mesa, California, United States
    Recruiting
Show 44 more locations
  • UCLA South Bay Endocrinology
    Torrance, California, United States
    Recruiting
  • Northeast Research Institute (NERI)
    Fleming Island, Florida, United States
    Recruiting
  • Encore Medical Research - Weston
    Weston, Florida, United States
    Recruiting
  • Orita Clinical Research
    Decatur, Georgia, United States
    Recruiting
  • Care Research
    Idaho Falls, Idaho, United States
    Recruiting
  • Cotton O'Neil Diabetes & Endocrinology
    Topeka, Kansas, United States
    Recruiting
  • Billings Clinic
    Billings, Montana, United States
    Recruiting
  • Excel Clinical Research, LLC
    Las Vegas, Nevada, United States
    Recruiting
  • Albany Medical College, Division of Community Endocrinology
    Albany, New York, United States
    Recruiting
  • NYC Research INC
    Long Island City, New York, United States
    Recruiting
  • Research Foundation of SUNY - University of Buffalo
    Williamsville, New York, United States
    Recruiting
  • University of North Carolina Medical Center
    Chapel Hill, North Carolina, United States
    Recruiting
  • Lucas Research, Inc.
    Hickory, North Carolina, United States
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Central States Research
    Tulsa, Oklahoma, United States
    Recruiting
  • Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • AM Diabetes & Endocrinology Center
    Bartlett, Tennessee, United States
    Recruiting
  • Velocity Clinical Research, Dallas
    Dallas, Texas, United States
    Recruiting
  • Prime Revival Research Institute, LLC
    Flower Mound, Texas, United States
    Recruiting
  • Juno Research
    Houston, Texas, United States
    Recruiting
  • PlanIt Research, PLLC
    Houston, Texas, United States
    Recruiting
  • Southern Endocrinology Associates
    Mesquite, Texas, United States
    Recruiting
  • Texas Valley Clinical Research
    Weslaco, Texas, United States
    Recruiting
  • Diabetes & Endocrine Treatment Specialists
    Sandy, Utah, United States
    Recruiting
  • Cedic
    Caba, Buenos Aires, Argentina
    Recruiting
  • CIMeL
    Lanus, Buenos Aires, Argentina
    Recruiting
  • Centro de Investigaciones Médicas Mar del Plata
    Mar del Plata, Buenos Aires, Argentina
    Recruiting
  • DIM Clínica Privada
    Ramos Mejía, Buenos Aires, Argentina
    Recruiting
  • Investigaciones Medicas Imoba Srl
    Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
    Recruiting
  • Ciprec
    Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
    Recruiting
  • Centro Médico Viamonte
    Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
    Recruiting
  • Mautalen Salud e Investigación
    Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
    Recruiting
  • Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
    Ciudad Autonoma de Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
    Recruiting
  • Centro de Investigaciones Clínicas Baigorria
    Granadero Baigorria, Santa Fe, Argentina
    Recruiting
  • INECO Neurociencias Oroño
    Rosario, Santa Fe, Argentina
    Recruiting
  • Instituto Médico Catamarca IMEC
    Rosario, Santa Fe, Argentina
    Recruiting
  • Instituto Médico Fundación Grupo Colaborativo Rosario Investigación y Prevención Medica
    Rosario, Santa Fe, Argentina
    Recruiting
  • Instituto de Investigaciones Clinicas Rosario
    Rosario, Santa Fe, Argentina
    Recruiting
  • Ciprec
    Buenos Aires, Argentina
    Recruiting
  • Centro de Investigaciones Metabólicas (CINME)
    Ciudad Autónoma de Buenos Aires, Argentina
    Recruiting
  • Centro Diabetológico Dr. Waitman
    Córdoba, Argentina
    Recruiting
  • Centro Médico Colón
    Córdoba, Argentina
    Recruiting
  • Centro de Endocrinologia Alcantara Gonzalez
    Bayamon, Puerto Rico
    Recruiting
  • Isis Clinical Research Center
    Guaynabo, Puerto Rico
    Recruiting

+30 more sites. See ClinicalTrials.gov for the full list.

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.